Ressler S et al (2006) p16INK4A is a robust in vivo biomarker of cellular aging in human skin
2003, 41: S13-S26
They are particularly effective for conditions like type 2 diabetes and PCOS, where insulin resistance plays a central role
Today peptides, tomorrow homeopathy (...though at least for the latter, a presumption of safety would have a more rational basis) Eric, what feels especially important here is that the difficult question is not only whether a biological signal exists, but whether the strength of evidence matches the level of confidence required for clinical use
MCC950, a selective NLRP3 inflammasome inhibitor, successfully suppressed TGF-1 + IL-1-induced NLRP3 inflammasome activation, as indicated by the downregulation of caspase-1 p20 (Fig
GSH is the most prominent antioxidant in RPE cells and is present at high concentration in retina and RPE 13,14